Science Vs Ivermectin: The Story of a Wonder Drug
15 snips
Apr 21, 2022 Dr. Pierre Kory, a critical care physician, shares his journey advocating for ivermectin during COVID-19. He discusses the initial excitement over ivermectin’s potential before the narrative soured, uncovering misinformation and ethical breaches in studies. The podcast explores the desperation doctors faced in overwhelmed ICUs and the clash between innovative treatments and traditional guidelines. It unpacks the controversy surrounding research on ivermectin and reflects on the broader implications for public health amidst conflicting narratives.
AI Snips
Chapters
Transcript
Episode notes
Pierre Kory's Steroid Advocacy
- Pierre Kory, a critical care physician, felt desperate during the early pandemic due to lack of effective COVID treatments.
- He advocated for steroids despite WHO opposition, eventually leaving his job due to the pushback, only to be vindicated later when studies proved steroids' efficacy.
Ivermectin's Potential
- Ivermectin, known for its anti-parasitic properties, gained attention for potential antiviral effects against COVID-19.
- Initial lab studies showed promise, but translating those findings to clinical settings required further investigation.
The Elgazar Paper
- An Egyptian study, the Elgazar paper, claimed impressive results with ivermectin, reporting a 94% recovery rate in severe COVID patients.
- This study significantly boosted Pierre Kory's confidence in ivermectin's potential.